Area of research
Oncology · Cancer Research
Research interest
Research focused on Breast cancer and Cancer research, with related work in Downregulation and upregulation, Oncology, Triple-negative breast cancer. Notable publications include 'Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance', 'Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients', and 'Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization'.
Efficacy and safety of KN026 and docetaxel for HER2‐positive breast cancer: a phase II clinical trial
OTUD7B is a new deubiquitinase targeting p53
Genomic mutation profile and metabolic alterations in diffuse large B-cell lymphoma with abdominal bulky mass
SMC4 promotes immune evasion by inhibiting endogenous interferon signaling and upregulating PD-L1 expression in triple negative breast cancer
Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer
Screening of optimal candidates for postoperative radiotherapy among patients with resectable thymic tumors: a multicenter retrospective study
Clinical Risk Stratification and Modifiable Risk Factors for Hepatitis B Virus-Related Follicular Lymphoma
Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells
Improving the diagnosis of ductal carcinoma in situ with microinvasion without immunohistochemistry: An innovative method with H&E‐stained and multiphoton microscopy images
Spatial tertiary lymphoid structures imply response to anti‐<scp>PD</scp>‐1 plus anlotinib in advanced non‐small cell lung cancer
CyTOF analysis revealed platelet heterogeneity in breast cancer patients received T-DM1 treatment
Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis
Sestrin2-mediated disassembly of stress granules dampens aerobic glycolysis to overcome glucose starvation
Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer
Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory
NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance—a bioinformatics analysis
APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
Prognostic significance of collagen signatures at breast tumor boundary obtained by combining multiphoton imaging and imaging analysis
CEBPA enhances tumor radiosensitivity through ferroptosis and associates with tumor immune microenvironment
Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis
CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma
Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months
Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients
Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization
LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling
LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance
Identification of spliceosome components pivotal to breast cancer survival